Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perylene | 4 | 2016 | 8 | 0.740 |
Why?
|
| Asparagine | 1 | 2011 | 8 | 0.400 |
Why?
|
| Acids | 1 | 2011 | 15 | 0.400 |
Why?
|
| Phosphatidylcholines | 1 | 2011 | 45 | 0.400 |
Why?
|
| Lipid Bilayers | 1 | 2011 | 66 | 0.370 |
Why?
|
| Lipids | 1 | 2011 | 222 | 0.350 |
Why?
|
| Imides | 2 | 2016 | 9 | 0.280 |
Why?
|
| Serum Albumin | 2 | 2016 | 49 | 0.260 |
Why?
|
| Liposomes | 3 | 2011 | 107 | 0.210 |
Why?
|
| Ginsenosides | 1 | 2017 | 4 | 0.150 |
Why?
|
| Amino Acids, Aromatic | 1 | 2015 | 5 | 0.140 |
Why?
|
| Radioisotopes | 2 | 2003 | 15 | 0.120 |
Why?
|
| Technetium | 2 | 2003 | 11 | 0.120 |
Why?
|
| Rhenium | 2 | 2003 | 12 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 569 | 0.110 |
Why?
|
| Capsules | 1 | 2011 | 24 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 75 | 0.100 |
Why?
|
| Alkylation | 2 | 2008 | 11 | 0.090 |
Why?
|
| Radiopharmaceuticals | 3 | 2003 | 55 | 0.090 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2008 | 5 | 0.080 |
Why?
|
| Naphthols | 1 | 2008 | 10 | 0.080 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 2 | 1998 | 10 | 0.080 |
Why?
|
| DNA Adducts | 2 | 1998 | 41 | 0.080 |
Why?
|
| Isotope Labeling | 2 | 2003 | 27 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 407 | 0.070 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2004 | 1 | 0.060 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2004 | 3 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2004 | 18 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 41 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2015 | 196 | 0.060 |
Why?
|
| Doxorubicin | 1 | 2003 | 80 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2003 | 68 | 0.060 |
Why?
|
| Protein Binding | 2 | 2016 | 913 | 0.050 |
Why?
|
| Chlorohydrins | 2 | 1998 | 2 | 0.050 |
Why?
|
| Mutation | 1 | 2004 | 1023 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2015 | 94 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2003 | 197 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1998 | 28 | 0.040 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 1998 | 4 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 195 | 0.040 |
Why?
|
| Circular Dichroism | 2 | 2013 | 60 | 0.040 |
Why?
|
| Drug Stability | 3 | 2003 | 110 | 0.040 |
Why?
|
| Benzopyrenes | 1 | 1997 | 6 | 0.040 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 4 | 0.040 |
Why?
|
| Solutions | 1 | 2016 | 60 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2017 | 30 | 0.040 |
Why?
|
| Solubility | 1 | 2016 | 115 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 157 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 376 | 0.030 |
Why?
|
| Solvents | 1 | 2015 | 93 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2015 | 76 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 1534 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 818 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1442 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2013 | 350 | 0.030 |
Why?
|
| Rats | 3 | 2003 | 3261 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 597 | 0.030 |
Why?
|
| Humans | 4 | 2017 | 34853 | 0.020 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2004 | 6 | 0.020 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2004 | 6 | 0.020 |
Why?
|
| Cytosine Deaminase | 1 | 2004 | 6 | 0.020 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2004 | 8 | 0.020 |
Why?
|
| Ammonium Sulfate | 1 | 2003 | 4 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 22 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2004 | 31 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2004 | 149 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 123 | 0.010 |
Why?
|
| Cysteine | 1 | 2003 | 88 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 53 | 0.010 |
Why?
|
| Animals | 3 | 2003 | 14307 | 0.010 |
Why?
|
| Glutathione | 1 | 2003 | 160 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 317 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 932 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 550 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 549 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1490 | 0.010 |
Why?
|
| Male | 3 | 2003 | 18870 | 0.010 |
Why?
|
| Densitometry | 1 | 1998 | 13 | 0.010 |
Why?
|
| Bay-Region, Polycyclic Aromatic Hydrocarbon | 1 | 1998 | 3 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1998 | 51 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1681 | 0.010 |
Why?
|
| Chlorides | 1 | 1998 | 52 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 162 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 78 | 0.010 |
Why?
|
| Halogens | 1 | 1997 | 2 | 0.010 |
Why?
|
| Deoxyadenosines | 1 | 1997 | 9 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 55 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 650 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1997 | 52 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1997 | 150 | 0.010 |
Why?
|
| Carcinogens | 1 | 1997 | 117 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1997 | 255 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1997 | 467 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 406 | 0.010 |
Why?
|